Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

AIMS: Dual antiplatelet therapy reduces non-fatal ischaemic events after acute coronary syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the prognostic impact of myocardial infarction (MI) vs. bleeding during an extended follow-up period to gain insight into the trad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J
Autors principals: Valgimigli, Marco, Costa, Francesco, Lokhnygina, Yuliya, Clare, Robert M., Wallentin, Lars, Moliterno, David J., Armstrong, Paul W., White, Harvey D., Held, Claes, Aylward, Philip E., Van de Werf, Frans, Harrington, Robert A., Mahaffey, Kenneth W., Tricoci, Pierluigi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837470/
https://ncbi.nlm.nih.gov/pubmed/28363222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw525
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars